New research finds that an empowering message, emphasizing a person's potential to manage addictions, is much more helpful.
The solution is not to turn off our phones; it's to develop social, economic, and political structures that address deeper issues of social disconnection and overwork.
At some level, we are all experiencing the Web's toxic possibilities. But as with other toxins, young developing bodies and brains are more susceptible.
Many sober homes have made the news recently for egregious violations—but the latest federal effort to clean them up may not do much to help.
This is the biggest state opioid settlement yet, and lawyers and addiction patients' advocates are waiting eagerly to see what precedent it will set.
A new major report finds that laws around medication for opioid addiction aren't based in science.
The popular notion of the opioid crisis primarily affecting rural communities does not hold up, according to new research.
In a sealed court document, one of the company's controlling members indicated that Purdue Pharma should not correct misconceptions about the strength of oxycodone.
The powerful painkiller has led to a considerable spike in overdoses in some border cities, but users are finding little support in trying to combat the scourge.
The maker of the potent painkiller Oxycontin discussed how the sale of opioids and the treatment of opioid addiction were "naturally linked."
A night on the job with Newark Assistant Fire Chief David Decker.
As the founder and president of Harm Reduction Ohio, Cauchon lobbies for progressive drug policies in the state—a position that can pit him not just against politicians, but also other reformers.
For people with substance use disorders, day reporting can provide a safe environment and a space for counseling or treatment.
The opioids are here, and meth is resurgent. When it's easier than ever to rationalize the first hit, and the options are limitless, even a community-wide effort might not be enough to stop the overdoses.
New research suggests that sexual minorities are particularly vulnerable to dependency on these drugs.
The Food and Drug Administration is approving a powerful new opioid painkiller, the agency announced Friday.
The declaration was met with a lot of fanfare, but officials did little with the legal powers it gave them, experts say.
A new study asks if insurance policies discourage the overprescribing of opioids and encourage proven alternative pain treatments.
A collection of some of our most important and timely stories, from a feature on California's progressive history to a photo essay capturing the lifelong effects of trauma.
An exclusive newsletter that brings premium members Pacific Standard stories, staff, and contributors directly to their inbox on a regular basis.